EGLN1 and alcoholic fatty liver disease: In a model for alcoholic fatty liver disease (AFLD), Phd2 hypomorph mice displayed a decrease in adiposity, a maintained insulin sensitivity, an improved lipoprotein profile and a reduced WAT inflammation in comparison to mice with Phd2 [79].